IONS
NASDAQ · Biotechnology
Ionis Pharmaceuticals Inc
$75.99
+0.10 (+0.13%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-4.93%
1Y
+91.70%
YTD
-4.62%
Open$75.89
Previous Close$75.89
Day High$77.31
Day Low$75.77
52W High$86.74
52W Low$36.11
Volume—
Avg Volume1.90M
Market Cap12.25B
P/E Ratio—
EPS$-2.10
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$80.92
Below
SMA 200
$60.03
Above
RSI (14)
47.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
33 analysts
Price Target
-1.4% upside
Current
$75.99
$75.99
Target
$74.94
$74.94
$58.43
$74.94 avg
$113.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 974.69M | 832.21M | 6.52B |
| Net Income | -393,903,345 | -302,692,119 | -1,853,302,223 |
| Profit Margin | -40.4% | -38.4% | -28.4% |
| EBITDA | -383,871,907 | -311,371,509 | -2,518,216,651 |
| Free Cash Flow | — | — | -1,126,512,375 |
| Rev Growth | +17.1% | +17.1% | -9.9% |
| Debt/Equity | 4.77 | 4.77 | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |